Physicians will have access to a wealth of information the very first time they see a patient. All will be revealed, from previous illnesses and treatments through to day-to-day stress factors and issues. These findings, biosignals and images will be sourced from the electronic files of other health facilities, and from patients' personal health and recrea-tional devices. Big data analytics will tap the experience gained in many similar cases and provide insight into therapy options. Even rare diseases will become easier to treat.
Doctors will also be able to test drug therapy options on physical models and optimize the regimen for the given patient. Medications produced on the basis of these models will help in the fight against rare diseases, and will drastically reduce drug use. Far fewer preclinical screenings and animal experiments will be needed to bring medicines to market.